Latest Insider Transactions at Monopar Therapeutics (MNPR)
This section provides a real-time view of insider transactions for Monopar Therapeutics (MNPR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Monopar Therapeutics to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Monopar Therapeutics's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2020
|
Michael J Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
322
+0.15%
|
-
|
|
Dec 31
2020
|
Raymond Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
322
+12.33%
|
-
|
|
Dec 31
2020
|
Arthur J Klausner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
322
+4.87%
|
-
|
|
Dec 31
2020
|
Christopher M Starr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
322
+19.99%
|
-
|
|
Sep 30
2020
|
Michael J Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
322
+0.15%
|
-
|
|
Sep 30
2020
|
Raymond Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
322
+14.07%
|
-
|
|
Sep 30
2020
|
Arthur J Klausner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
322
+5.12%
|
-
|
|
Sep 30
2020
|
Christopher M Starr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
322
+24.98%
|
-
|